News
akampion hosts expert panel at BIO-Europe 2017, co-authors scientific article in Human Gene Therapy
akampion to host expert panel on successful corporate communications at BIO-Europe 2017
We are happy to announce that akampion is a silver sponsor of this year’s BIO-Europe in Berlin and will host an expert panel on successful corporate communications in a changing media and investment world. The discussion will focus on the needs of both healthcare-savvy media / investors and generalists and how companies can address these needs.
Panelists include
- Stephen Hansen, Ass. Editor, BioCentury;
- Sascha Karberg, Science Writer, Der Tagesspiegel and Transkript;
- Eva v. Schaper, Science Writer;
- Cormac Sheridan, Science Journalist, BioWorld Today; and
- Mike Ward, Global Director of Content, Informa Pharma Insights.
The panel is scheduled on Monday, Nov. 6, 9:00 – 10:30am, City Cube Berlin, Level 3, Room M6. Further information can be found on the BIO-Europe website.
It would be a pleasure to see you at our panel at BIO-Europe. For one-on-one meetings, please feel free to send us a meeting request via BIO-Europe´s online partnering system or by sending an e-mail to info@akampion.com. We look forward to catching up with you in Berlin!
New peer-reviewed article in Human Gene Therapy co-authored by akampion
Moreover, a scientific review written by akampion together with our client Provecs Medical will be published in the December issue of Human Gene Therapy, a peer-reviewed rapid-publication journal covering all aspects of human gene therapy. The article “Immuno-Oncology – the translational runway for gene therapy” appeared online http://online.liebertpub.com/doi/pdfplus/10.1089/hum.2017.145 on October 25, 2017.
Further expanding client roster
In the last months, we have also further expanded our portfolio by a number of new clients with outstanding products and technologies, e.g. BioNTech AG, Phenex Pharmaceuticals, Heidelberg Immunotherapeutics, and Provecs Medical.